XINQI Amlodipine Besylate Tablets For Hypertension 5mg*14

(No reviews yet) Write a Review
$12.99
Origin:
China
Manufacturer:
XINQI
Form:
Tablets
Specification:
5mg*14
Storage Life:
60 months
Adding to cart… The item has been added

Product Overview

【Generic name】
Amlodipine besylate tablets

【Drug name】
Xinqi Amlodipine besylate tablets

【Main ingredients】
Amlodipine besylate.

【Functions and indications】
1. Hypertension. This product is suitable for the treatment of hypertension. It can be used alone or in combination with other antihypertensive drugs.

【Usage and dosage】
The usual oral starting dose is 5mg, once a day, and the maximum does not exceed 10mg, once a day. Thin people, weak constitution...

【Properties】
This product is a white tablet.

【Adverse reactions】
The safety of this product has relatively complete data in clinical studies in the United States and other countries, involving more than 11,000 patients. In general, patients have good tolerance for the use of this product in a daily dose range of 10MG. Adverse reactions reported during the treatment of this product are mostly mild or moderate. The most common side effects are headache and edema. 1. Cardiovascular system: arrhythmia, bradycardia, chest pain, hypotension, peripheral ischemia, syncope, tachycardia, postural dizziness, postural hypotension, vasculitis. 2. Central and peripheral nervous system: hypoesthesia, peripheral neuropathy, paresthesia, tremor, vertigo. 3. Gastrointestinal system: anorexia, constipation, indigestion, dysphagia, diarrhea, flatulence, pancreatitis, vomiting, gingival hyperplasia. 4. Systemic: allergic reaction, fatigue, back pain, hot flashes, general malaise, pain, stiffness, weight gain, weight loss. 5. Musculoskeletal system: joint pain, arthritis, muscle cramps, myalgia. 6. Psychiatry: sexual dysfunction, insomnia, nervousness, depression, abnormal dreams, anxiety, personality disorder. 7. Respiratory system: dyspnea, epistaxis. 8. Skin and appendages: angioedema, erythema multiforme, pruritus, rash, erythematous rash, maculopapular rash. 9. Special senses: visual abnormalities, conjunctivitis, diplopia, eye pain, tinnitus. 10. Urinary system: frequent urination, abnormal urination, nocturia. 11. Autonomic nervous system: dry mouth, sweating. 12. Nutritional metabolism: hyperglycemia, thirst. 13. Hematopoietic system: leukopenia, purpura, thrombocytopenia. In placebo-controlled studies, the incidence of these events was less than 1%, but in all multi-dose studies, the incidence of these side effects was between 1% and 2%. Expand

【Contraindications】
Patients who are allergic to dihydropyridine drugs or any of the ingredients in this product are contraindicated.

【Precautions】
1. Angina pectoris and/or myocardial infarction: rare. Patients with severe obstructive coronary artery disease may experience an increase in the frequency, duration and/or severity of angina attacks, or develop acute myocardial infarction, when they start treatment with calcium channel antagonists or increase the dosage. The mechanism is unknown. 2. Hypotension: Since this product gradually produces vasodilation, acute hypotension rarely occurs when taken orally. However, caution is still required when this product is used in combination with other peripheral vasodilators, especially for patients with severe aortic stenosis. 3. Patients with heart failure: Calcium channel blockers should be used with caution in patients with heart failure. 4. Patients with hepatic insufficiency: This product should be used with caution in patients with severe hepatic insufficiency. 5. Patients with renal failure: The starting dose of patients with renal failure can remain unchanged. 6. This product can be used safely in patients with obstructive pulmonary disease, well-compensated heart failure, peripheral vascular disease, diabetes and lipid disorders. Expand

【Interactions】
1. Cimetidine, grapefruit juice, acidogens: The pharmacokinetics of this product are not changed when used in combination.

【Storage conditions】
Light-shielded and sealed.

【Specifications】
14 tablets/box

【Approval number】
National Medicine Standard H20083834

【Manufacturer】
Shandong Xinqi Pharmaceutical Co., Ltd.

Reviews

(No reviews yet) Write a Review